Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction

[1]  A. Pession,et al.  Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series , 2023, Journal of Neuro-Oncology.

[2]  D. McComb,et al.  Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy , 2023, Nature Nanotechnology.

[3]  Seon-Jin Lee,et al.  Autophagy mediates an amplification loop during ferroptosis , 2023, Cell death & disease.

[4]  Lifang Yin,et al.  Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment. , 2023, Biomaterials.

[5]  Zhe S Chen,et al.  Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. , 2023, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[6]  Yihui Gong,et al.  AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus , 2023, Cell death discovery.

[7]  A. Matheu,et al.  Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment , 2023, Theranostics.

[8]  Mengcen Wang,et al.  Phyllosphere microbiome induces host metabolic defence against rice false-smut disease , 2023, Nature Microbiology.

[9]  X. Yang,et al.  Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma , 2023, Advanced science.

[10]  G. Wang,et al.  Synergistic Apoptosis-Ferroptosis: Oxaliplatin loaded amorphous iron oxide nanoparticles for High-efficiency therapy of orthotopic pancreatic cancer and CA19-9 levels decrease , 2023, Chemical Engineering Journal.

[11]  C. Arús,et al.  Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs? , 2023, Nanomaterials.

[12]  Xianzhu Yang,et al.  Rigid Shell Decorated Nanodevice with Fe/H2O2 Supply and Glutathione Depletion Capabilities for Potentiated Ferroptosis and Synergized Immunotherapy , 2023, Advanced Functional Materials.

[13]  Baoli Hu,et al.  Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models , 2023, STAR protocols.

[14]  Meng Zheng,et al.  Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma , 2022, Nature Communications.

[15]  Dingming Huang,et al.  Ferroptosis interaction with inflammatory microenvironments: Mechanism, biology, and treatment. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Chen Jiang,et al.  A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy. , 2022, Small.

[17]  J. Moreno-Navarrete,et al.  The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism , 2022, Nature Reviews Endocrinology.

[18]  Li Zhang,et al.  Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis. , 2022, Nanoscale.

[19]  B. Stockwell.  Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications , 2022, Cell.

[20]  Tingting Wang,et al.  Targeted Immunoimaging of Tumor-Associated Macrophages in Orthotopic Glioblastoma by the NIR-IIb Nanoprobes. , 2022, Small.

[21]  Chunyan Dong,et al.  A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Q. Mei,et al.  Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma. , 2022, ACS nano.

[23]  R. Willumeit-Römer,et al.  Mg-based materials diminish tumor spreading and cancer metastases , 2022, Bioactive materials.

[24]  R. Taboła,et al.  MMP9: A Tough Target for Targeted Therapy for Cancer , 2022, Cancers.

[25]  Q. Mei,et al.  Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM , 2022, Journal of Nanobiotechnology.

[26]  Yingyi Wang,et al.  Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status , 2022, Frontiers in Immunology.

[27]  U. Hofmann,et al.  T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 , 2022, Nature communications.

[28]  Chen Zhu,et al.  Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. , 2022, Neuro-oncology.

[29]  Ahsan Ayub,et al.  An Overview of Nanotechnologies for Drug Delivery to the Brain , 2022, Pharmaceutics.

[30]  S. Schreiber,et al.  Persister cancer cells: Iron addiction and vulnerability to ferroptosis. , 2021, Molecular cell.

[31]  Y. Leng,et al.  Activation of NRF2/FPN1 pathway attenuates myocardial ischemia–reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis , 2021, Cell Stress and Chaperones.

[32]  M. Hadamitzky,et al.  Glioma: molecular signature and crossroads with tumor microenvironment , 2021, Cancer and Metastasis Reviews.

[33]  A. Roldão,et al.  Functionalizing Ferritin Nanoparticles for Vaccine Development , 2021, Pharmaceutics.

[34]  P. Gean,et al.  Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor , 2021, International journal of molecular sciences.

[35]  Jie Tian,et al.  Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting , 2021, Science China Life Sciences.

[36]  Jennifer L. Hadley,et al.  Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. , 2021, JAMA oncology.

[37]  S. Koyama,et al.  Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies , 2021, Journal for ImmunoTherapy of Cancer.

[38]  Q. Mei,et al.  Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Cynthia A. Reinhart-King,et al.  Mechanoresponsive metabolism in cancer cell migration and metastasis. , 2021, Cell metabolism.

[40]  Fan Wu,et al.  Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients , 2021, Genom. Proteom. Bioinform..

[41]  Junxia Xie,et al.  New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases , 2021, Molecular Neurobiology.

[42]  Yili Yang,et al.  A natural drug entry channel in the ferritin nanocage , 2020 .

[43]  Zhongliang Wang,et al.  Rabies Virus-Inspired Metal-Organic Frameworks for Targeted Imaging and Chemotherapy of Glioma. , 2020, Angewandte Chemie.

[44]  Zbynek Heger,et al.  Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[45]  K. Davies,et al.  Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma , 2020, Journal of Neuro-Oncology.

[46]  Yan-zhong Chang,et al.  Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice. , 2020, Life sciences.

[47]  L. Colvin.  Chemotherapy-induced peripheral neuropathy: where are we now? , 2019, Pain.

[48]  A. Kim,et al.  Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction , 2018, Journal of Neuro-Oncology.

[49]  J. Conde,et al.  Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma. , 2018, ACS nano.

[50]  Xiaoyuan Chen,et al.  Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self‐Assembled Metal‐Phenolic Network Nanoparticles , 2018, Advanced materials.

[51]  M. Castells,et al.  Presentation and Diagnosis of Hypersensitivity to Platinum Drugs , 2015, Current Allergy and Asthma Reports.

[52]  S. Stylli,et al.  Mouse models of glioma , 2015, Journal of Clinical Neuroscience.

[53]  M. Gütschow,et al.  Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin. , 2013, Pharmazie.

[54]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas , 2009, Journal of Neuro-Oncology.

[55]  R. Perez,et al.  Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells. , 1996, Cancer letters.